TY - JOUR
T1 - Childhood pneumonia increases risk for chronic obstructive pulmonary disease
T2 - The COPDGene study
AU - Hayden, Lystra P.
AU - Hobbs, Brian D.
AU - Cohen, Robyn T.
AU - Wise, Robert A.
AU - Checkley, William
AU - Crapo, James D.
AU - Hersh, Craig P.
N1 - Funding Information:
Supported by National Institutes of Health (NIH) grants T32 HL007427, R01HL094635, R01NR013377, P01HL105339, R01HL089897 and R01HL089856. The COPDGene® project is also supported by the COPD Foundation through contributions made to an Industry Advisory Board comprised of AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Novartis, Pfizer, Siemens, Sunovion and Image Analysis. Neither the NIH nor the COPD Foundation Industry Advisory Board had a role in the study design, collection, analysis and interpretation of the data, writing of the manuscript or the decision to submit the paper for publication.
Publisher Copyright:
© 2015 Hayden et al.
PY - 2015/9/21
Y1 - 2015/9/21
N2 - Background: Development of adult respiratory disease is influenced by events in childhood. The impact of childhood pneumonia on chronic obstructive pulmonary disease (COPD) is not well defined. We hypothesize that childhood pneumonia is a risk factor for reduced lung function and COPD in adult smokers. Methods: COPD cases and control smokers between 45-80 years old from the United States COPDGene Study were included. Childhood pneumonia was defined by self-report of pneumonia at <16 years. Subjects with lung disease other than COPD or asthma were excluded. Smokers with and without childhood pneumonia were compared on measures of respiratory disease, lung function, and quantitative analysis of chest CT scans. Results: Of 10,192 adult smokers, 854 (8.4 %) reported pneumonia in childhood. Childhood pneumonia was associated with COPD (OR 1.40; 95 % CI 1.17-1.66), chronic bronchitis, increased COPD exacerbations, and lower lung function: post-bronchodilator FEV1 (69.1 vs. 77.1 % predicted), FVC (82.7 vs. 87.4 % predicted), FEV1/FVC ratio (0.63 vs. 0.67; p < 0.001 for all comparisons). Childhood pneumonia was associated with increased airway wall thickness on CT, without significant difference in emphysema. Having both pneumonia and asthma in childhood further increased the risk of developing COPD (OR 1.85; 95 % CI 1.10-3.18). Conclusions: Children with pneumonia are at increased risk for future smoking-related lung disease including COPD and decreased lung function. This association is supported by airway changes on chest CT scans. Childhood pneumonia may be an important factor in the early origins of COPD, and the combination of pneumonia and asthma in childhood may pose the greatest risk. Clinical trials registration: ClinicalTrials.gov, NCT00608764(Active since January 28, 2008).
AB - Background: Development of adult respiratory disease is influenced by events in childhood. The impact of childhood pneumonia on chronic obstructive pulmonary disease (COPD) is not well defined. We hypothesize that childhood pneumonia is a risk factor for reduced lung function and COPD in adult smokers. Methods: COPD cases and control smokers between 45-80 years old from the United States COPDGene Study were included. Childhood pneumonia was defined by self-report of pneumonia at <16 years. Subjects with lung disease other than COPD or asthma were excluded. Smokers with and without childhood pneumonia were compared on measures of respiratory disease, lung function, and quantitative analysis of chest CT scans. Results: Of 10,192 adult smokers, 854 (8.4 %) reported pneumonia in childhood. Childhood pneumonia was associated with COPD (OR 1.40; 95 % CI 1.17-1.66), chronic bronchitis, increased COPD exacerbations, and lower lung function: post-bronchodilator FEV1 (69.1 vs. 77.1 % predicted), FVC (82.7 vs. 87.4 % predicted), FEV1/FVC ratio (0.63 vs. 0.67; p < 0.001 for all comparisons). Childhood pneumonia was associated with increased airway wall thickness on CT, without significant difference in emphysema. Having both pneumonia and asthma in childhood further increased the risk of developing COPD (OR 1.85; 95 % CI 1.10-3.18). Conclusions: Children with pneumonia are at increased risk for future smoking-related lung disease including COPD and decreased lung function. This association is supported by airway changes on chest CT scans. Childhood pneumonia may be an important factor in the early origins of COPD, and the combination of pneumonia and asthma in childhood may pose the greatest risk. Clinical trials registration: ClinicalTrials.gov, NCT00608764(Active since January 28, 2008).
UR - http://www.scopus.com/inward/record.url?scp=84959158233&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84959158233&partnerID=8YFLogxK
U2 - 10.1186/s12931-015-0273-8
DO - 10.1186/s12931-015-0273-8
M3 - Article
C2 - 26392057
AN - SCOPUS:84959158233
SN - 1465-9921
VL - 16
JO - Respiratory research
JF - Respiratory research
IS - 1
M1 - 115
ER -